Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 321 followers
Latest posts
Last updated 1 day ago
Roche purchases shares in tender offer for 89bio, Inc
1 day ago
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
3 days ago
New dengue antigen test delivers high clinical sensitivity and specificity, as well...
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
4 days ago
Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved...
Changes to the Roche Enlarged Corporate Executive Committee
9 days ago
Basel, 23 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong sales growth momentum of 7% (CER) in the first nine months of 2025; full-year earnings outlook raised
9 days ago
Basel, 23 October 2025 Group sales grew by 7%1 at constant exchange...
Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment
12 days ago
Tecentriq reduced the risk of death by 41% and the risk of...
FDA approves Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis
12 days ago
FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as...
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
14 days ago
Giredestrant plus everolimus reduced the risk of disease progression or death by...
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
14 days ago
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving...
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
14 days ago
Positive recommendation based on phase II NOBILITY and phase III REGENCY data...
Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025
16 days ago
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial...
Roche data at ESMO 2025 showcase advances in science and cancer care across multiple tumour types
19 days ago
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...